Russell Thomas Zepeda, PA-C

Russell Zepeda practices at Methodist Hospital Atascosa in Jourdanton, Texas, part of HCA Healthcare.

Russell Zepeda's NPI, 1518162122, was assigned on June 15, 2007. Russell Zepeda holds Texas license PA05276.

Russell Zepeda's primary practice is Methodist Hospital Atascosa, at 1905 Hwy 97 East, Jourdanton, TX 78026 in Atascosa County. The practice phone is (830) 769-3515.

Russell Zepeda's primary practice is Methodist Hospital Atascosa in Jourdanton, Texas, part of HCA Healthcare. The medical group on file is Emergency Medicine Services of TX, PLLC. Dmand AI also links Russell Zepeda to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Russell Zepeda practices. Vendor and product names are available with a free account.

Physician assistant is Russell Zepeda's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Russell Zepeda is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Russell Zepeda is licensed in Texas.

Dmand AI lists acute sinusitis, acute skin infection, bronchitis, conjunctivitis, lower back pain, minor injury to a limb, muscle weakness and shingles among the conditions Russell Zepeda treats.

CMS data shows 322 Medicare services from Russell Zepeda across 3 procedure codes in 2024, for 289 Medicare patients. Medicare paid $28,217 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 289 Medicare patients who saw Russell Zepeda in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Russell Zepeda's median patient age at 42, with 55% women.

In 2024, Russell Zepeda wrote 504 Medicare Part D claims for 340 patients. 96% of them were for generic drugs. CMS names the drug for 344 of them, across 16 drugs with 11 or more claims each, at $5,012 in total drug cost.